- Communication with the Surgical Team:
Effective communication can achieve the desired timing for emergence. Knowing the estimated time remaining in the surgery helps the anesthesia provider plan when to reduce or stop anesthetics. Surgeons may request a quick wake-up for immediate postoperative assessments (e.g., neuro exams) or a slow, controlled wake-up for cases where movement could disrupt a surgical site. Clear and respectful communication can prevent misunderstandings between the surgical and anesthesia teams.
- Discontinuation of Inhaled Agents:
Inhaled anesthetics like isoflurane, sevoflurane, and desflurane have different pharmacokinetics, so their discontinuation must be timed appropriately:
- Isoflurane: This longer-acting agent should be reduced earlier in the procedure, typically 45 to 60 minutes before the desired wake-up time.
- Sevoflurane and Desflurane: These shorter-acting agents can be continued closer to the end of the surgery but should still be titrated down during the last 15-20 minutes.
- Total Intravenous Anesthesia (TIVA) Management:
When using TIVA, the wake-up process can be more complex due to the context-sensitive half-time of drugs like propofol, which increases with prolonged administration.
- Titrating Propofol: Gradually reducing the propofol infusion throughout the surgery helps prevent a delayed wake-up. Toward the end of the case, propofol can be decreased to 70-80 mcg/kg/min and reduced during the skin closure phase to around 40-50 mcg/kg/min. For prolonged cases, a slower reduction may be needed to avoid residual drug effects.
- Supplementing with Nitrous Oxide: In cases where rapid wake-up is needed, switching to nitrous oxide toward the end of the case can help bridge the gap as propofol is reduced. Nitrous oxide is rapidly eliminated and can provide sufficient anesthetic depth, allowing for faster emergence.
- Reversal of Neuromuscular Blockade:
If using neostigmine and glycopyrrolate, the reversal should be initiated as soon as the deeper layers of surgical closure (e.g., fascia) are completed, as the full effect may take up to 15-20 minutes. Sugammadex, used for reversing rocuronium and vecuronium, provides faster reversal and can be administered later in the procedure.
- Managing Opioids and Other Adjuncts:
Opioids like fentanyl or remifentanil are often used during the procedure but should be titrated carefully to avoid residual sedation or respiratory depression during emergence. With its short half-life, Remifentanil is turned off about 20 minutes before extubation. Longer-acting opioids, such as morphine, should be minimized toward the end of the case and balanced with non-opioid analgesics or regional techniques to prevent prolonged sedation and respiratory compromise.
| Agent | Timing | Why |
|---|---|---|
| Isoflurane | Reduce 45–60 minutes before the desired wake-up time | Longer-acting agent |
| Sevoflurane, desflurane | Can be continued closer to the end, but titrate down over the last 15–20 minutes | Shorter-acting agents |
| Propofol (TIVA) | Reduce gradually through the case — to 70–80 mcg/kg/min toward the end and 40–50 mcg/kg/min during skin closure | Context-sensitive half-time increases with prolonged administration; prolonged cases may need a slower reduction |
| Nitrous oxide | Switch to it toward the end of the case when a rapid wake-up is needed | Rapidly eliminated, so it bridges depth as propofol is reduced |
| Neostigmine with glycopyrrolate | Start as soon as the deeper layers of closure, such as fascia, are completed | Full effect may take up to 15–20 minutes |
| Sugammadex | Can be administered later in the procedure | Faster reversal of rocuronium and vecuronium |
| Remifentanil | Turn off about 20 minutes before extubation | Short half-life |
| Longer-acting opioids (e.g., morphine) | Minimize toward the end of the case | Balance with non-opioid analgesics or regional techniques to prevent prolonged sedation and respiratory compromise |
